Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
BI-771716 by Boehringer Ingelheim International for Geographic Atrophy: Likelihood of Approval
BI-771716 is under clinical development by Boehringer Ingelheim International and currently in Phase I for Geographic Atrophy. According to GlobalData,...